Abstract
Title compds. I, their pharmaceutical compns., pharmaceutically acceptable salts, hydrates, solvates, complexes, and prodrugs, are prepd. and disclosed as CRTH2 antagonists for the treatment of allergic diseases. Title compds. I [W = Cl or F; R1 = (un)substituted phenyl], their pharmaceutically acceptable salts, hydrates, solvates, complexes, and prodrugs, are claimed. For example, compd. II was prepd. via reaction of 2-fluoro-3-pyridinecarboxaldehyde with benzenesulfinic acid sodium salt to yield 2-(benzenesulfonyl)isonicotinaldehyde, which underwent reaction with (5-fluoro-2-methylindol-1-yl)acetic acid Et ester, followed by hydrolysis of the ester moiety. Select I were assayed for CRTH2 antagonist activity and found to possess Ki values of 1-979 nM. [on SciFinder(R)]
Author supplied keywords
Cite
CITATION STYLE
Armer, R. E., Pettipher, E. R., Whittaker, M., Wynne, G. M., Vile, J., & Schroer, Frank. (2009, July 23). (Indol-1-yl)acetic acid derivatives and their pharmaceutical compositions as CRTH2 antagonists for the treatment of allergic diseases and preparation thereof. PCT Int. Appl. Oxagen Limited, UK .
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.